|
Volumn 95, Issue 2, 1995, Pages 612-621
|
Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge
a a a a a a a |
Author keywords
adhesion molecules; allergic conjunctivitis; Allergic inflammation; antiallergic drugs; cetirizine; ICAM 1 CD54
|
Indexed keywords
ALLERGEN;
CETIRIZINE;
INTERCELLULAR ADHESION MOLECULE 1;
PLACEBO;
ADULT;
ALLERGIC CONJUNCTIVITIS;
ANTIGEN EXPRESSION;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONJUNCTIVA EPITHELIUM;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG MECHANISM;
EYELID EDEMA;
FEMALE;
HUMAN;
HYPEREMIA;
INFLAMMATORY CELL;
LACRIMATION;
MALE;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
PRURITUS;
RANDOMIZED CONTROLLED TRIAL;
RHINOCONJUNCTIVITIS;
ADOLESCENT;
ADULT;
ALLERGENS;
CETIRIZINE;
CONJUNCTIVA;
CONJUNCTIVITIS, ALLERGIC;
DOUBLE-BLIND METHOD;
EPITHELIUM;
EPITOPES;
FEMALE;
HUMANS;
INTERCELLULAR ADHESION MOLECULE-1;
MALE;
RHINITIS, ALLERGIC, SEASONAL;
TIME FACTORS;
|
EID: 0028897165
PISSN: 00916749
EISSN: None
Source Type: Journal
DOI: 10.1016/S0091-6749(95)70324-1 Document Type: Article |
Times cited : (161)
|
References (40)
|